New Clinical Trials Available at Texas Retina
At Texas Retina, we remain committed to conducting ongoing research that will advance retinal care. That is why for over 20 years, for physicians have participated in more than 100 national clinical
read moreDr. Wang Invited to Serve as Guest Lecturer at Ohio State University
Texas Retina’s Robert C. Wang will speak at The Ohio State University’s 7th Annual Retina Case Forum on Friday, August 16, 2024, as an invited guest lecturer. The event is a case-based
read moreTexas Retina Recognizes Jennifer Hagger Ward for 26+ Years of Service
We continue to recognize Texas Retina team members who have served our practice for 20 years or more. Today, we are honoring Jennifer Hager Ward, who joined Texas Retina in 1997, and
read moreKimberly Jones Recognized for 26+ Years of Service to Texas Retina
We are continuing to celebrate our team members who have been a part of the Texas Retina family for 20 years or more. Today we recognize Kimberly Jones who joined our team
read moreCelebrating Sarah Yarletts’ 26+ Years of Service to Texas Retina
We continue to recognize Texas Retina team members who have served our practice for 20 years or more. Today, we honor Sarah Yarletts, who joined Texas Retina in 1997 and currently serves
read moreDr. Wang Participated in Roundtable Discussion on XIPERE Treatment for Macular Edema Associated with Uveitis
At the most recent American Academy of Ophthalmology (AAO) Annual Meeting in Chicago, Texas Retina Associates’ Robert Wang, MD, participated in a roundtable discussion with seven other retina specialists to share their
read moreNew Clinical Trials Available
At Texas Retina Associates, our physicians remain actively involved in conducting research that will improve care for our patients, offering access to promising new retinal treatments through clinical trials. We recently opened
read moreFour New Clinical Trials Available at Texas Retina Associates
Our physicians remain committed to participating in ongoing retina research and providing our patients access to promising new treatment options through clinical trials. We recently opened four new clinical trials: Diabetic Macular
read more